Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,527 | -57,457 | -71,728 | -96,712 | -82,910 |
| Depreciation Amortization | 77 | 232 | 284 | 309 | 347 |
| Accounts payable and accrued liabilities | -59 | -6,140 | -1,503 | 3,568 | 4,545 |
| Other Working Capital | -2,096 | -8,289 | -4,739 | 3,429 | 8,126 |
| Other Operating Activity | 9,634 | 18,115 | 29,702 | 17,328 | 56 |
| Operating Cash Flow | $-44,971 | $-53,539 | $-47,984 | $-72,078 | $-69,836 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -67 | -35 | -130 | -12 | -161 |
| Other Investing Activity | 250 | -25 | 0 | 0 | -12 |
| Investing Cash Flow | $183 | $-60 | $-130 | $-12 | $-173 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 5,000 | 75,000 | 50,000 |
| Debt Issued | 14,805 | N/A | N/A | 5,000 | 14,633 |
| Debt Repayment | -9,111 | -7,482 | -2,805 | -687 | N/A |
| Common Stock Issued | 8,975 | 23,437 | 88,068 | 15 | 11 |
| Other Financing Activity | 44,467 | 19,663 | -2,236 | -502 | -226 |
| Financing Cash Flow | $59,136 | $35,618 | $88,027 | $78,826 | $64,418 |
| Beginning Cash Position | 32,787 | 50,768 | 10,855 | 4,119 | 9,710 |
| End Cash Position | 47,135 | 32,787 | 50,768 | 10,855 | 4,119 |
| Net Cash Flow | $14,348 | $-17,981 | $39,913 | $6,736 | $-5,591 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,971 | -53,539 | -47,984 | -72,078 | -69,836 |
| Capital Expenditure | -67 | -35 | -130 | -12 | -161 |
| Free Cash Flow | -45,038 | -53,574 | -48,114 | -72,090 | -69,997 |